Leukemia & Lymphoma, Volume 61, Issue 14 (2020)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 61, Issue 14 (2020)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Volume 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentary

Article Commentary
How should clinicians interpret conflicting cost-effectiveness analyses for the treatment of lymphoma across nations and payer models?
R. Andrew Harkins & Christopher R. Flowers
Pages: 3283-3286
Published online: 04 Nov 2020
First Page PreviewforHow should clinicians interpret conflicting cost-effectiveness analyses for the treatment of lymphoma across nations and payer models? | Full Text | References | PDF (379.1 KB) | EPUB
  • 191 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Selection and management of older patients with acute myeloid leukemia treated with glasdegib plus low-dose cytarabine: expert panel review
Jorge E. Cortes, Anna Candoni, Richard E. Clark, Brian Leber, Pau Montesinos, Paresh Vyas, Amer M. Zeidan & Michael Heuser
Pages: 3287-3305
Published online: 24 Sep 2020
AbstractforSelection and management of older patients with acute myeloid leukemia treated with glasdegib plus low-dose cytarabine: expert panel review | Full Text | References | PDF (1.9 MB) | EPUB | Supplemental
  • 2123 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access

Original Articles

Article
Clinical characteristics and survival of extranodal natural killer/T-cell lymphoma: a single-center 12-year retrospective analysis
Yi Chen, Luting Luo, Xiaoyun Zheng, Haiying Fu, Xiaozhu Yang, Wanling Huang, Lushan Chen, Zhihong Zheng, Jing Zheng, Ting Yang, Tingbo Liu & Jianda Hu
Pages: 3306-3318
Published online: 21 Aug 2020
AbstractforClinical characteristics and survival of extranodal natural killer/T-cell lymphoma: a single-center 12-year retrospective analysis | Full Text | References | PDF (2 MB) | EPUB | Supplemental
  • 159 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
Classic Hodgkin lymphoma post-transplant lymphoproliferative disorders (PTLD) are often preceded by discordant PTLD subtypes
Ryan J. Stubbins, Curtis Mabilangan, Marta Rojas-Vasquez, Raymond L. Lai, James Zhu, Jutta P. Preiksaitis & Anthea C. Peters
Pages: 3319-3330
Published online: 02 Sep 2020
AbstractforClassic Hodgkin lymphoma post-transplant lymphoproliferative disorders (PTLD) are often preceded by discordant PTLD subtypes | Full Text | References | PDF (2.7 MB) | EPUB
  • 275 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
Modified SMILE (mSMILE) and intensity-modulated radiotherapy (IMRT) for extranodal NK-T lymphoma nasal type in a single-center population
Paola Ghione, Shunan Qi, Brandon S. Imber, Venkatraman Seshan, Alison Moskowitz, Natasha Galasso, Matthew Lunning, David Straus, Craig Sauter, Parastoo Dahi, Ahmet Dogan, Joachim Yahalom & Steven Horwitz
Pages: 3331-3341
Published online: 26 Aug 2020
AbstractforModified SMILE (mSMILE) and intensity-modulated radiotherapy (IMRT) for extranodal NK-T lymphoma nasal type in a single-center population | Full Text | References | PDF (1.7 MB) | EPUB
  • 1357 Views
  • 16 CrossRef citations
  • 0Altmetric
Article
Clinicopathological and prognostic significance of BCL2, BCL6, MYC, and IRF4 copy number gains and translocations in follicular lymphoma: a study by FISH analysis
Meejeong Kim, Hee Sang Hwang, Eun Mi Son, Hyungwoo Cho, Dok Hyun Yoon, Cheolwon Suh, Chan Sik Park, Heounjeong Go & Jooryung Huh
Pages: 3342-3350
Published online: 13 Sep 2020
AbstractforClinicopathological and prognostic significance of BCL2, BCL6, MYC, and IRF4 copy number gains and translocations in follicular lymphoma: a study by FISH analysis | Full Text | References | PDF (2 MB) | EPUB | Supplemental
  • 405 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Analysis and impact of a multidisciplinary lymphoma virtual tumor board
Thomas M. Habermann, Arushi Khurana, Ruth Lentz, John J. Schmitz, Alexander G. von Bormann, Jason R. Young, Christopher H. Hunt, Sara N. Christofferson, Grzegorz S. Nowakowski, Kristen B. McCullough, Pedro Horna, Adam J. Wood, William R. Macon, Paul J. Kurtin, Scott C. Lester, Scott L. Stafford, Ushrasree Chamarthy, Faraz Khan, Stephen M. Ansell & Rebecca L. King
Pages: 3351-3359
Published online: 23 Sep 2020
AbstractforAnalysis and impact of a multidisciplinary lymphoma virtual tumor board | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 410 Views
  • 12 CrossRef citations
  • 0Altmetric
Article
Adjuvant chemotherapy administration and survival outcomes of lymphoma survivors with common solid tumors: a population-based study†
Mengyang Di, Orestis A. Panagiotou, John L. Reagan, Rabin Niroula & Adam J. Olszewski
Pages: 3360-3368
Published online: 11 Sep 2020
AbstractforAdjuvant chemotherapy administration and survival outcomes of lymphoma survivors with common solid tumors: a population-based study† | Full Text | References | PDF (1.7 MB) | EPUB | Supplemental
  • 106 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Response rates, long term outcomes and toxicity profile of gemcitabine and vinorelbine based outpatient chemotherapy regimen in primary progressive and relapsed childhood Hodgkin lymphoma
Mir Rooh Ullah Jan, Haleema Saeed, Muhammad Abubakar & Rabia Muhammad Wali
Pages: 3369-3377
Published online: 13 Sep 2020
AbstractforResponse rates, long term outcomes and toxicity profile of gemcitabine and vinorelbine based outpatient chemotherapy regimen in primary progressive and relapsed childhood Hodgkin lymphoma | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 220 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Second primary malignancy after rituximab-containing immunochemotherapy for diffuse large B cell lymphoma
Yoshiaki Chinen, Kazuna Tanba, Ryo Takagi, Hitoji Uchiyama, Nobuhiko Uoshima, Kazuho Shimura, Shin-ichi Fuchida, Miki Kiyota, Mitsushige Nakao, Taku Tsukamoto, Yuji Shimura, Tsutomu Kobayashi, Shigeo Horiike, Katsuya Wada, Chihiro Shimazaki, Hiroto Kaneko, Yutaka Kobayashi, Masafumi Taniwaki, Isao Yokota, Junya Kuroda & Kyoto Clinical Hematology Study Group investigators
Pages: 3378-3386
Published online: 27 Aug 2020
AbstractforSecond primary malignancy after rituximab-containing immunochemotherapy for diffuse large B cell lymphoma | Full Text | References | PDF (781.5 KB) | EPUB | Supplemental
  • 382 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Cost-effectiveness of polatuzumab vedotin in relapsed or refractory diffuse large B-cell lymphoma
Kishan K. Patel, Iris Isufi, Shalin Kothari, Francine Foss & Scott Huntington
Pages: 3387-3394
Published online: 24 Aug 2020
AbstractforCost-effectiveness of polatuzumab vedotin in relapsed or refractory diffuse large B-cell lymphoma | Full Text | References | PDF (980 KB) | EPUB | Supplemental
  • 811 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
The influence of programmed cell death ligand 2 (PD-L2) expression on survival outcome and tumor microenvironment in diffuse large B cell lymphoma
San Krittikarux, Kitsada Wudhikarn, Nichthida Tangnuntachai, Thamathorn Assanasen, Narittee Sukswai, Thiti Asawapanumas & Chantiya Chanswangphuwana
Pages: 3395-3403
Published online: 21 Aug 2020
AbstractforThe influence of programmed cell death ligand 2 (PD-L2) expression on survival outcome and tumor microenvironment in diffuse large B cell lymphoma | Full Text | References | PDF (1,010.1 KB) | EPUB | Supplemental
  • 213 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Identifying high-risk patients with natural killer/T-cell lymphoma undergoing autologous stem cell transplantation
Bing Bai, Yan Gao, Xiao-Xiao Wang, Hai-Xia He, Li-Qin Ping, Peng-Fei Li, Cheng Huang, Qi-Chun Cai & Hui-Qiang Huang
Pages: 3404-3411
Published online: 20 Aug 2020
AbstractforIdentifying high-risk patients with natural killer/T-cell lymphoma undergoing autologous stem cell transplantation | Full Text | References | PDF (993.7 KB) | EPUB | Supplemental
  • 132 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Characteristics and outcome of patients with relapsed/refractory Hodgkin lymphoma following front-line escalated BEACOPP-based chemotherapy: a report from the Australasian Lymphoma Alliance
Matthew Harwood, Georgina Hodges, Xuan Tan, Chan Y. Cheah, Kenneth Lim, Matthew Ku, Constantine Tam, Ingemar Lagerlof & Tara Cochrane
Pages: 3412-3416
Published online: 28 Aug 2020
AbstractforCharacteristics and outcome of patients with relapsed/refractory Hodgkin lymphoma following front-line escalated BEACOPP-based chemotherapy: a report from the Australasian Lymphoma Alliance | Full Text | References | PDF (740.3 KB) | EPUB
  • 176 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Diagnosing lymphoma in the shadow of an epidemic: lessons learned from the diagnostic challenges posed by the dual tuberculosis and HIV epidemics
Katherine Antel, Vernon Johan Louw, Gary Maartens, Jenna Oosthuizen, Dharshnee Chetty & Estelle Verburgh
Pages: 3417-3421
Published online: 13 Sep 2020
AbstractforDiagnosing lymphoma in the shadow of an epidemic: lessons learned from the diagnostic challenges posed by the dual tuberculosis and HIV epidemics | Full Text | References | PDF (854.3 KB) | EPUB
  • 1358 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Changes in primary and secondary hemostasis in patients with CLL treated with venetoclax and ibrutinib
Rebecka Svanberg, Sisse Rye Ostrowski, Kazem Nasserinejad, Sabina Kersting, Johan A. Dobber, Mattias Mattson, Hoa T. T. Tran, Mark-David Levin, Rogier Mous, Arnon P. Kater & Carsten U. Niemann
Pages: 3422-3431
Published online: 31 Aug 2020
AbstractforChanges in primary and secondary hemostasis in patients with CLL treated with venetoclax and ibrutinib | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 352 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Comparison of acalabrutinib plus obinutuzumab, ibrutinib plus obinutuzumab and venetoclax plus obinutuzumab for untreated CLL: a network meta-analysis
Zhixin Sheng, Shilei Song, Miao Yu, Hongguang Zhu, Anran Gao, Weijie Gao, Xuehong Ran & Da Huo
Pages: 3432-3439
Published online: 30 Aug 2020
AbstractforComparison of acalabrutinib plus obinutuzumab, ibrutinib plus obinutuzumab and venetoclax plus obinutuzumab for untreated CLL: a network meta-analysis | Full Text | References | PDF (2.1 MB) | EPUB
  • 937 Views
  • 15 CrossRef citations
  • 0Altmetric
Article
Clinical characteristics, therapeutic management, and prognostic factors of adult COVID-19 inpatients with hematological malignancies
Yaogong Wu, Wenlan Chen, Wenjing Li, Miaomiao Zhao, Qiuzhe Wei, Xiaoping Zhang, Heng Mei, Yadan Wang & Yu Hu
Pages: 3440-3450
Published online: 25 Aug 2020
AbstractforClinical characteristics, therapeutic management, and prognostic factors of adult COVID-19 inpatients with hematological malignancies | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 2144 Views
  • 11 CrossRef citations
  • 0Altmetric
Article
Let-7b regulates the adriamycin resistance of chronic myelogenous leukemia by targeting AURKB in K562/ADM cells
Xue Zhou, Xiancheng Ma, Hang Sun, Xue Li, Huizhen Cao, Youzhang Jiang, Pingyu Wang, Shuyang Xie, Youjie Li & Yunxiao Sun
Pages: 3451-3459
Published online: 28 Aug 2020
AbstractforLet-7b regulates the adriamycin resistance of chronic myelogenous leukemia by targeting AURKB in K562/ADM cells | Full Text | References | PDF (2.2 MB) | EPUB | Supplemental
  • 107 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
Minimal residual disease surveillance at day 90 predicts long-term survival in pediatric patients with T-cell acute lymphoblastic leukemia
Xiaoming Liu, Yao Zou, Xiaojuan Chen, Shuchun Wang, Ye Guo, Wenyu Yang, Li Zhang, Yumei Chen, Yingchi Zhang & Xiaofan Zhu
Pages: 3460-3467
Published online: 11 Aug 2020
AbstractforMinimal residual disease surveillance at day 90 predicts long-term survival in pediatric patients with T-cell acute lymphoblastic leukemia | Full Text | References | PDF (1 MB) | EPUB
  • 242 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Prognostic value of MRD monitoring based on BCR-ABL1 copy numbers in Philadelphia chromosome positive acute lymphoblastic leukemia
Arun Kumar Arunachalam, Nancy Beryl Janet, Anu Korula, Kavitha M. Lakshmi, Uday P. Kulkarni, Fouzia N. Aboobacker, Aby Abraham, Biju George, Poonkuzhali Balasubramanian & Vikram Mathews
Pages: 3468-3475
Published online: 27 Aug 2020
AbstractforPrognostic value of MRD monitoring based on BCR-ABL1 copy numbers in Philadelphia chromosome positive acute lymphoblastic leukemia | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 269 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Balanced and unbalanced chromosomal translocations in myelodysplastic syndromes: clinical and prognostic significance
Sara Mohamed, Roberto Latagliata, Maria Zaira Limongi, Stefania Nigro, Eleonora Sangiorgi, Mauro Nanni, Annalina Piccioni, Alessia Campagna, Maria Antonietta Aloe Spiriti, Ida Carmosino, Matteo Molica, Elena Mariggiò, Serena Rosati, Gioia Colafigli, Francesca Fazio, Maria Lucia De Luca, Daniela De Benedittis, Emilia Scalzulli, Massimo Breccia & Marco Mancini
Pages: 3476-3483
Published online: 01 Sep 2020
AbstractforBalanced and unbalanced chromosomal translocations in myelodysplastic syndromes: clinical and prognostic significance | Full Text | References | PDF (1,002.3 KB) | EPUB | Supplemental
  • 126 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Busulfan, melphalan, and bortezomib compared to melphalan as a high dose regimen for autologous hematopoietic stem cell transplantation in multiple myeloma: long term follow up of a novel high dose regimen
Patrick Hagen, Anita D'Souza, Parameswaran Hari, Omar Davila, Mei-Jie Zhang, David H. Vesole, Scott E. Smith, Tulio E. Rodriguez & Patrick J. Stiff
Pages: 3484-3492
Published online: 31 Aug 2020
AbstractforBusulfan, melphalan, and bortezomib compared to melphalan as a high dose regimen for autologous hematopoietic stem cell transplantation in multiple myeloma: long term follow up of a novel high dose regimen | Full Text | References | PDF (1,013.9 KB) | EPUB
  • 1211 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Glucocorticoid receptor expression in multiple myeloma patients is a predictor of survival
Alexander Pozhitkov, Michael Rosenzweig, Flavia Pichiorri, Emine G. Gunes, Ralf Buettner, Jonathan J. Keats & Steven T. Rosen
Pages: 3493-3497
Published online: 13 Sep 2020
AbstractforGlucocorticoid receptor expression in multiple myeloma patients is a predictor of survival | Full Text | References | PDF (931.8 KB) | EPUB
  • 1463 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access

Letters to the Editor

Letter
Reclassification of subtypes in Philadelphia chromosome-negative myeloproliferative neoplasm by 2016 WHO diagnostic criteria: focus on the cases classified as myeloproliferative neoplasm, unclassifiable by the 2008 version
Jiwon Yun, Jung-Ah Kim, Junseo Park, Kyongok Im, Young Eun Lee, Dajeong Jeong, Sohee Ryu, Kyu Min Lim, Sung-Min Kim, Yong-Oon Ahn & Dong Soon Lee
Pages: 3498-3502
Published online: 02 Sep 2020
First Page PreviewforReclassification of subtypes in Philadelphia chromosome-negative myeloproliferative neoplasm by 2016 WHO diagnostic criteria: focus on the cases classified as myeloproliferative neoplasm, unclassifiable by the 2008 version | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 1206 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Letter
Ethnic disparities in survival of adult B-cell acute lymphoblastic leukemia in modern era – a SEER analysis
Nishi Shah, Bradley Rockwell, Mohammad Kazemi, Stephen Peeke, Lizamarie Bachier-Rodriguez, Roberto Alejandro Sica, Mendel Goldfinger, Noah Kornblum, Ira Braunschweig, Aditi Shastri, Amit Verma & Ioannis Mantzaris
Pages: 3503-3506
Published online: 22 Sep 2020
First Page PreviewforEthnic disparities in survival of adult B-cell acute lymphoblastic leukemia in modern era – a SEER analysis | Full Text | References | PDF (434.7 KB) | EPUB | Supplemental
  • 163 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Use of dasatinib dose-reduction periods to remedy poor surgical wound healing in Philadelphia chromosome-positive acute lymphoblastic leukemia
Kandice E. Roberts, Michael W. Deininger, Gerhard C. Hildebrandt, Brian K. Gackenbach & Maxwell M. Krem
Pages: 3507-3510
Published online: 24 Aug 2020
First Page PreviewforUse of dasatinib dose-reduction periods to remedy poor surgical wound healing in Philadelphia chromosome-positive acute lymphoblastic leukemia | Full Text | References | PDF (894.4 KB) | EPUB | Supplemental
  • 264 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
UK national audit of extracorporeal photopheresis (ECP) in chronic graft versus host disease
Francesca A. M. Kinsella, Alvin Bencito, Daniela Kulik, Erin Hurst, Maria Gilleece, John A. Snowden, Ram Malladi, Julia Scarisbrick, Andrew Gennery & Arun Alfred
Pages: 3511-3514
Published online: 02 Sep 2020
First Page PreviewforUK national audit of extracorporeal photopheresis (ECP) in chronic graft versus host disease | Full Text | References | PDF (680 KB) | EPUB | Supplemental
  • 187 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Aberrant leukemia-associated immunophenotype as potential harbinger of lineage switch in KMT2A-rearranged leukemia: a case series
Christine M. Yost, Amos S. Gaikwad, D. Williams Parsons, Karen R. Rabin, Vincent U. Gant, Kevin E. Fisher, Andrea N. Marcogliese & Eric S. Schafer
Pages: 3515-3518
Published online: 02 Sep 2020
First Page PreviewforAberrant leukemia-associated immunophenotype as potential harbinger of lineage switch in KMT2A-rearranged leukemia: a case series | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 192 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
Syngeneic transplants for multiple myeloma – a single center experience and review of the literature
Eyal Lebel, Anca Prica, Sita Bhella, Vishal Kukreti, Rodger Tiedemann, Suzanne Trudel, Donna Reece & Christine Chen
Pages: 3519-3522
Published online: 14 Sep 2020
First Page PreviewforSyngeneic transplants for multiple myeloma – a single center experience and review of the literature | Full Text | References | PDF (487.6 KB) | EPUB
  • 184 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Efficacy and safety of ruxolitinib for Covid-19 related acute respiratory distress syndrome in a patient with blastic plasmacytoid dendritic cell neoplasm (leukemic variant)
Vincenzo Sammartano, Adele Santoni, Bruno Frediani, Anna Sicuranza, Cencini Emanuele, Federico Franchi, Enrico Capochiani & Monica Bocchia
Pages: 3523-3525
Published online: 09 Sep 2020
First Page PreviewforEfficacy and safety of ruxolitinib for Covid-19 related acute respiratory distress syndrome in a patient with blastic plasmacytoid dendritic cell neoplasm (leukemic variant) | Full Text | References | PDF (325.3 KB) | EPUB
  • 818 Views
  • 4 CrossRef citations
  • 0Altmetric
Letter
Cytogenetically cryptic and fish negative PML/RARA rearrangement in acute promyelocytic leukemia detected by RT-PCR
Georgia Avgerinou, Κaterina Katsibardi, Maria Filippidou, Marianna Tzanoudaki, Stefanos I. Papadhimitriou & Antonis Kattamis
Pages: 3526-3528
Published online: 10 Sep 2020
First Page PreviewforCytogenetically cryptic and fish negative PML/RARA rearrangement in acute promyelocytic leukemia detected by RT-PCR | Full Text | References | PDF (807.4 KB) | EPUB
  • 257 Views
  • 3 CrossRef citations
  • 0Altmetric
Letter
A comparison of bendamustine-EAM versus BEAM conditioning for autogolous stem cell transplant in lymphoma
Alexander Glover, Christopher P. Fox, Andrew McMillan, Amy Beech, Nicholas Martinez-Calle, Catherine Griffiths, Faith Richardson, Nigel Russell & Mark J. Bishton
Pages: 3529-3531
Published online: 08 Sep 2020
First Page PreviewforA comparison of bendamustine-EAM versus BEAM conditioning for autogolous stem cell transplant in lymphoma | Full Text | References | PDF (463.5 KB) | EPUB
  • 127 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Retreatment with venetoclax and hypomethylating agents among AML patients who have relapsed after initial response and subsequent interruption of therapy
Tamer A. Othman, Jianying Zhang, Matthew Mei, Anthony S. Stein, Stephen J. Forman, Guido Marcucci, Vinod Pullarkat & Ibrahim Aldoss
Pages: 3532-3533
Published online: 19 Aug 2020
CitationforRetreatment with venetoclax and hypomethylating agents among AML patients who have relapsed after initial response and subsequent interruption of therapy | Full Text | References | PDF (252.5 KB) | EPUB
  • 316 Views
  • 4 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia
Jennifer Marvin-Peek et al.
Article | Published online: 15 May 2024
Mitigating time toxicity in lymphoma and multiple myeloma
Mengyang Di et al.
Review Article | Published online: 15 May 2024
Pharmacokinetics of idelalisib in chronic lymphocytic leukemia and follicular lymphoma disclose better outcomes for patients with lower exposure
Fabien Despas et al.
Letter to the Editor | Published online: 15 May 2024
Prevalence and clinicopathological features of incidentally detected TRBC1-dim populations in peripheral blood flow cytometry
Paul Wadsworth et al.
Letter to the Editor | Published online: 15 May 2024
View all latest articles